Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OveRcoming immunosupprEssion aNd rebAlancing the Immune reSponSe in ovAriaN CancEr Study

NCT06611072 is registered in ClinicalTrials.gov with Gynaecologisch Oncologisch Centrum Zuid as lead sponsor.

NCT NCT06611072
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06611072 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OveRcoming immunosupprEssion aNd rebAlancing the Immune reSponSe in ovAriaN CancEr Study
Lead sponsor
Gynaecologisch Oncologisch Centrum Zuid
Phase
Not applicable
Overall status
Recruiting
Start date
January 1, 2025
Completion date
December 31, 2027
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immune suppression, immune system suppression, ovarian cancer, ovarian carcinoma, ovarian neoplasms